发明名称 Production of Humanized Immunoglobulins
摘要 Compsn. comprises a pure human-like immunoglobulin (Ig) which (a) reacts specifically with p55 Tac protein and/or (b) inhibits binding of human interleukin-2 (IL-2) to its receptor. Also new are (1) human-like Ig having 2 pairs of light/heavy chains and able to react specifically with an epitope of a human IL-2 receptor with affinity at least 10 power 8 per mole, the chains including complementarily determg. regions (CDR's) and human-like framework regions (FR's), the CDR's being from different Ig molecules than FR's; (2) humanised Ig (hIg) which can bind to IL-2 receptors and contain at least one CDR from anti-Tac antibody in a human-like FR contg. at least one amino acid from the anti-Tac antibody; (3) nucleic acid encoding for human-like FR and at least one murine CDR, and (4) cells transfected with nucleic acid.
申请公布号 EP1491556(B1) 申请公布日期 2014.04.30
申请号 EP20040076438 申请日期 1989.12.28
申请人 PDL BIOPHARMA, INC. 发明人 QUEEN, CARY L.;SELICK, HAROLD E.
分类号 C07K16/00;C12N15/09;A61K;A61K38/00;A61K39/395;A61P3/10;A61P19/02;A61P21/04;A61P25/00;A61P29/00;A61P37/00;A61P37/06;C07K1/22;C07K14/435;C07K14/705;C07K14/715;C07K16/08;C07K16/18;C07K16/24;C07K16/28;C07K16/46;C07K19/00;C12M;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N5/28;C12N7/01;C12N15/00;C12N15/10;C12N15/13;C12P21/00;C12P21/08;C12R1/91 主分类号 C07K16/00
代理机构 代理人
主权项
地址